{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:27:00Z","timestamp":1793046420516,"version":"4.5.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/bor.0b013e32834ff2fd","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T04:06:14Z","timestamp":1326427574000},"page":"171-176","source":"Crossref","is-referenced-by-count":77,"title":["Risk factors for cardiovascular disease in rheumatoid arthritis"],"prefix":"10.1097","volume":"24","author":[{"given":"Sherine E.","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/rheumatology\/ker232","article-title":"Cardiovascular risk and rheumatoid arthritis: the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.","volume":"50","author":"Kozera","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3442","article-title":"Cardiovascular events in early rheumatoid arthritis (RA) are a result of inflammatory burden and traditional risk factors: a five year prospective study.","volume":"13","author":"Innala","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/ker258","article-title":"Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis.","volume":"50","author":"Bergstrom","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional risk factors in rheumatoid arthritis: a meta-analysis.","volume":"78","author":"Boyer","year":"2011","journal-title":"Joint Bone Spine"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10067-011-1775-5","article-title":"Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis: a cohort study.","volume":"30","author":"Rojas-Serrano","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis.","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis.","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin Immunol"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3899\/jrheum.100564","article-title":"Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a Greek cohort study.","volume":"38","author":"Serelis","year":"2011","journal-title":"J Rheumatol"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/ard.2009.126128","article-title":"Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study.","volume":"69","author":"Semb","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02041560","article-title":"Serum lipids and lipoprotein concentrations in women with rheumatoid arthritis.","volume":"2","author":"Heldenberg","year":"1983","journal-title":"Clin Rheumatol"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/24.3.250","article-title":"Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.","volume":"24","author":"Lorber","year":"1985","journal-title":"Br J Rheumatol"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-9120(88)80094-8","article-title":"Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis.","volume":"21","author":"Lakatos","year":"1988","journal-title":"Clin Biochem"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/ard.53.8.551","article-title":"Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.","volume":"53","author":"Kavanaugh","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"R16-9-20210128","first-page":"78","article-title":"Lipid profile improves with the onset of rheumatoid arthritis.","volume":"68","author":"Myasoedova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2009.122374","article-title":"Total cholesterol and LDL levels decrease before rheumatoid arthritis.","volume":"69","author":"Myasoedova","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2-3","key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.","volume":"28","author":"Hahn","year":"2007","journal-title":"J Autoimmun"},{"key":"R19-9-20210128","first-page":"64","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in nonrheumatoid arthritis patients Ann Rheum D","volume":"67","author":"Gonzalez","year":"2008","journal-title":"is"},{"key":"R20-9-20210128","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis: the Third National Health and Nutrition Examination Survey.","volume":"32","author":"Choi","year":"2005","journal-title":"J Rheumatol"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/keq295","article-title":"Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial.","volume":"50","author":"Semb","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R22-9-20210128","first-page":"683","article-title":"Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk Ann Rheum D","volume":"69","author":"Toms","year":"2010","journal-title":"is"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","article-title":"Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.","volume":"38","author":"Steiner","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016110791112269","article-title":"Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors.","volume":"8","author":"Toms","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","article-title":"Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.","volume":"70","author":"Kitas","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.semarthrit.2011.04.003","article-title":"The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.","volume":"41","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/art.30239","article-title":"Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.","volume":"63","author":"Bartels","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3899\/jrheum.100346","article-title":"3rd, et al. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.","volume":"38","author":"Crowson","year":"2011","journal-title":"J Rheumatol"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.","volume":"196","author":"Chung","year":"2008","journal-title":"Atherosclerosis"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2011.04.018","article-title":"The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk.","volume":"10","author":"Gremese","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.22053","article-title":"Insulin resistance and impaired beta cell function in rheumatoid arthritis.","volume":"54","author":"Dessein","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","article-title":"Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.","volume":"165","author":"Escalante","year":"2005","journal-title":"Arch Intern Med"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.","volume":"50","author":"Maradit Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","article-title":"Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England.","volume":"40","author":"Symmons","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R37-9-20210128","first-page":"525","article-title":"Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis.","volume":"5","author":"Voigt","year":"1994","journal-title":"Epidemiology"},{"key":"R38-9-20210128","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2008.095596","article-title":"Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.","volume":"68","author":"Stavropoulos-Kalinoglou","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R40-9-20210128","first-page":"681","article-title":"Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis.","volume":"34","author":"Dessein","year":"2007","journal-title":"J Rheumatol"},{"key":"R41-9-20210128","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/art.27629","article-title":"Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics.","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R42-9-20210128","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.23650","article-title":"High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.","volume":"58","author":"Kremers","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R43-9-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease A prospective study.","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R44-9-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R45-9-20210128","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.ATV.18.5.768","article-title":"Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992.","volume":"18","author":"Koenig","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R46-9-20210128","first-page":"1","article-title":"Hemorheological disturbances in patients with chronic cerebrovascular diseases.","volume":"31","author":"Szapary","year":"2004","journal-title":"Clin Hemorheol Microcirc"},{"key":"R47-9-20210128","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","article-title":"Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.","volume":"17","author":"Smith","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R48-9-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.atherosclerosis.2011.08.026","article-title":"Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients.","volume":"219","author":"Santos","year":"2011","journal-title":"Atherosclerosis"},{"key":"R49-9-20210128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2010.148031","article-title":"Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.","volume":"70","author":"Marder","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R50-9-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.","volume":"216","author":"Rodriguez-Rodriguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"R51-9-20210128","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.30323","article-title":"3rd, Knutson KL, Strausbauch MA, et al. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.","volume":"63","author":"Davis","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R52-9-20210128","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R53-9-20210128","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: a retrospective cohort study from disease onset.","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"R54-9-20210128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R55-9-20210128","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.amjcard.2007.11.076","article-title":"Cardiovascular outcomes in male veterans with rheumatoid arthritis.","volume":"101","author":"Banerjee","year":"2008","journal-title":"Am J Cardiol"},{"key":"R56-9-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R57-9-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.2006.053710","article-title":"Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis.","volume":"66","author":"Maradit-Kremers","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R58-9-20210128","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events.","volume":"36","author":"Liang","year":"2009","journal-title":"J Rheumatol"},{"key":"R59-9-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anticyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.","volume":"61","author":"Lopez-Longo","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R60-9-20210128","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/ard.2009.110536","article-title":"The effect of rheumatoid factor on mortality and coronary heart disease.","volume":"69","author":"Tomasson","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R61-9-20210128","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.25009","article-title":"Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.","volume":"61","author":"Rho","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R62-9-20210128","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/art.23811","article-title":"The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis.","volume":"58","author":"Wolfe","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R63-9-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.2006.056390","article-title":"Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.","volume":"66","author":"Farragher","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R64-9-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000173494","article-title":"Autoantibodies predicting death due to cardiovascular disease.","volume":"69","author":"Aho","year":"1982","journal-title":"Cardiology"},{"key":"R65-9-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","article-title":"Nonsteroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.","volume":"68","author":"Goodson","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R67-9-20210128","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R68-9-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R69-9-20210128","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R70-9-20210128","first-page":"667","article-title":"Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis Arthritis R","volume":"58","author":"Listing","year":"2008","journal-title":"heum"},{"key":"R71-9-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","article-title":"Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.","volume":"70","author":"Greenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R72-9-20210128","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/j.1755-5922.2009.00119.x","article-title":"Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.","volume":"28","author":"Turiel","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"R73-9-20210128","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32834ff2fd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:00Z","timestamp":1786047960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201203000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32834ff2fd","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}